90Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery
Authors:
- Juan C. CamachoJCJuan C. Camacho
- Valeria MoncayoVMValeria Moncayo
- Nima KokabiNKNima Kokabi
- Hamilton E. ReaveyHRHamilton E. Reavey
- James R. GaltJGJames R. Galt
- Kei YamadaKYKei Yamada
- Darren D. KiesDKDarren D. Kies
- Roger S. WilliamsRWRoger S. Williams
- Hyun S. KimHKHyun S. Kim
- David M. SchusterDSDavid M. Schuster
- 1 September 2015
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 35 (5) , 1602-1618
Abstract
Primary and metastatic liver cancers are responsible for considerable morbidity and mortality, and many patients are not curable at presentation. Therefore, new therapies such as radioembolization with yttrium 90 (90Y)–labeled microspheres are an alternative method to treat patients with unresectable primary or secondary liver tumors. Patient selection, treatment technique, and early recognition of potential complications are the keys for successful patient outcomes. The activity of administered 90Y microspheres depends on multiple variables, including the tumor burden, the volume of the liver lobe to be treated, the type of 90Y microspheres, and the hepatopulmonary shunt fraction. Preprocedural planning relies on the results of cross-sectional imaging to determine the extent of disease, tumoral and nontumoral liver volumes, patency of the portal vein, and the degree of extrahepatic disease. A multidisciplinary approach that combines expertise in cross-sectional imaging, nuclear medicine, and flow dynamic...Keywords
This publication has 57 references indexed in Scilit:
- 90 Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectivenessJournal of Comparative Effectiveness Research, 2013
- Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignanciesMedical Physics, 2011
- Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the LiverInternational Journal of Hepatology, 2011
- Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2010
- Unresectable Chemorefractory Liver Metastases: Radioembolization with90Y Microspheres—Safety, Efficacy, and SurvivalRadiology, 2008
- Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and SurvivalJournal of Vascular and Interventional Radiology, 2005
- Yttrium-90 Microsphere Therapy for Hepatic Malignancy: Devices, Indications, Technical Considerations, and Potential ComplicationsRadioGraphics, 2005
- Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic MalignanciesJournal of Clinical Oncology, 2000
- Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheresInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991